S
AMED

SignatureFD’s Amedisys AMED Stock Holding History

SignatureFD’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,380
Closed -$431K – 3382
2025
Q2 		$431K Buy
4,380
+1,775
+68% +$168K 0.01% 612
2025
Q1 		$241K Buy
2,605
+1,158
+80% +$107K ﹤0.01% 803
2024
Q4 		$131K Buy
1,447
+80
+6% +$7.35K ﹤0.01% 1083
2024
Q3 		$132K Buy
1,367
+236
+21% +$23K ﹤0.01% 1074
2024
Q2 		$104K Buy
1,131
+530
+88% +$49.2K ﹤0.01% 1143
2024
Q1 		$55.4K Buy
601
+286
+91% +$26.8K ﹤0.01% 1491
2023
Q4 		$29.9K Sell
315
-35
-10% -$3.27K ﹤0.01% 1724
2023
Q3 		$32.7K Sell
350
-15
-4% -$1.39K ﹤0.01% 1612
2023
Q2 		$33.4K Sell
365
-16
-4% -$1.31K ﹤0.01% 1645
2023
Q1 		$28K Buy
381
+86
+29% +$7.44K ﹤0.01% 1687
2022
Q4 		$24.6K Buy
295
+222
+304% +$20K ﹤0.01% 1702
2022
Q3 		$7K Buy
73
+4
+6% +$477 ﹤0.01% 2227
2022
Q2 		$7K Sell
69
-307
-82% -$39.2K ﹤0.01% 2272
2022
Q1 		$65K Buy
376
+281
+296% +$42K ﹤0.01% 1241
2021
Q4 		$15K Buy
95
+27
+40% +$4.34K ﹤0.01% 1901
2021
Q3 		$10K Sell
68
-6
-8% -$1.25K ﹤0.01% 2048
2021
Q2 		$18K Sell
74
-18
-20% -$4.72K ﹤0.01% 1747
2021
Q1 		$24K Buy
92
+31
+51% +$8.74K ﹤0.01% 1490
2020
Q4 		$18K Buy
61
+19
+45% +$4.87K ﹤0.01% 1484
2020
Q3 		$10K Hold
42
– – ﹤0.01% 1625
2020
Q2 		$8K Buy
42
+5
+14% +$933 ﹤0.01% 1627
2020
Q1 		$7K Buy
37
+7
+23% +$1.25K ﹤0.01% 1571
2019
Q4 		$5K Buy
+30
New +$4.46K ﹤0.01% 1623

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SignatureFD's AMED Position: Q3 2025 in Review

SignatureFD sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,380 shares — an estimated $431K sold.

SignatureFD first reported a position in AMED in Q4 2019 and held it in 23 quarters. The position peaked at $431K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • SignatureFD reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • SignatureFD sold 4,380 Amedisys shares in Q3 2025, an estimated $431K.
  • SignatureFD first reported a position in Amedisys in Q4 2019 and held it in 23 quarters.
  • SignatureFD's Amedisys position peaked at $431K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on SignatureFD's 13F filing for Q3 2025, filed 21 Oct 2025.